Profil
Richard Béliveau was the founder of Katana Biopharma, Inc. (2016) and Angiochem, Inc. (2003), holding the title of Principal from 2003 to 2010 at Angiochem, Inc. Former job includes Partner & Head-Investor Relations at Morneau Sobeco Income Fund.
Education includes a doctorate from Université Laval, conferred in 1980.
Anciens postes connus de Richard Béliveau
| Sociétés | Poste | Fin |
|---|---|---|
Morneau Sobeco Income Fund
Morneau Sobeco Income Fund Investment ManagersFinance Provides human resources consulting and outsourcing services | Public Communications Contact | 04/01/2011 |
Katana Biopharma, Inc.
Katana Biopharma, Inc. Hospital/Nursing ManagementHealth Services Operates oncology related technology platform | Fondateur | - |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Fondateur | - |
Formation de Richard Béliveau
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Morneau Sobeco Income Fund
Morneau Sobeco Income Fund Investment ManagersFinance Provides human resources consulting and outsourcing services | Finance |
Angiochem, Inc.
Angiochem, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for brain diseases | Health Technology |
Université Laval
Université Laval Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Katana Biopharma, Inc.
Katana Biopharma, Inc. Hospital/Nursing ManagementHealth Services Operates oncology related technology platform | Health Services |
















